Tag: (AZN)

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 4.15%.However, over the last six months, we can see a weaker performance of 8.89%. Over the last 30 days, the price of AZN has fallen by 5.98%. And in the last five days, it has surged by 2.06%. Astrazeneca plc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $76.56 on 04/25/23 and the lowest value

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price gain of 1.57% this year. Over the last six months, there has been a weaker performance of 1.47%. The price of AZN fallen by 2.87% during the last 30 days period. For the last 5-days stocks have improved 2.10%. Astrazeneca plc ADR’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $76.56 on 04/25/23 and a low of $60.47 for the

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 0.25% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 1.38%. Over the past 30 days, the price of AZN has fallen by 8.45%. And in the last five days, it has surged by 4.18%. Astrazeneca plc ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Astrazeneca plc ADR’s current trading price is -15.31% away from its 52-week high, while its distance from the 52-week low is 7.23%. The stock’s price range for this period has been between $60.47 and $76.56 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.5 million for the day, a number notably lower than the average daily volume of 6.42 million over the last three months. Astrazeneca plc ADR ‘s stock market performance